Full Text View
Tabular View
No Study Results Posted
Related Studies
Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania (InterACT)
This study has been completed.
Study NCT00885287   Information provided by University of Copenhagen

First Received on April 20, 2009.   Last Updated on January 15, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria, Falciparum
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Malaria
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Parasitic Diseases
Protozoan Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Artemether-lumefantrine (AL)
Additional drug interventions recognized in this trial
Artemether
Artemether-lumefantrine combination
Artemisinins
Lumefantrine
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Antifungal Agents
Antimalarials
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Coccidiostats
Pharmacologic Actions
Schistosomicides
Therapeutic Uses
Sponsors listed in this trial
University of Copenhagen
National Institute for Medical Research, Tanzania
London School of Hygiene and Tropical Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services